Arama Sonuçları - Marten A. Lantinga
- Gösterilen 1 - 7 sonuçlar arası kayıtlar. 7
-
1
Evaluation of hepatic cystic lesions Yazar: Marten A. Lantinga
Baskı/Yayın Bilgisi 2013Revisão -
2
Prevention of overuse: A view on upper gastrointestinal endoscopy Yazar: Judith J. de Jong, Marten A. Lantinga, Joost P.H. Drenth
Baskı/Yayın Bilgisi 2019Revisão -
3
Impact of the COVID-19 pandemic on gastrointestinal endoscopy in the Netherlands: analysis of a prospective endoscopy database Yazar: Marten A. Lantinga, Felix Theunissen, Pieter C. J. ter Borg, Marco J. Bruno, Rob J. Ouwendijk, Peter D. Siersema
Baskı/Yayın Bilgisi 2020Artigo -
4
Management of renal cyst infection in patients with autosomal dominant polycystic kidney disease: a systematic review Yazar: Marten A. Lantinga, Niek F. Casteleijn, Alix Geudens, Ruud G.L. de Sévaux, Sander van Assen, Anna M. Leliveld, Ron T. Gansevoort, Joost P.H. Drenth
Baskı/Yayın Bilgisi 2016Revisão -
5
Effect of Lanreotide on Kidney Function in Patients With Autosomal Dominant Polycystic Kidney Disease Yazar: Esther Meijer, Folkert W. Visser, R. Aerts, Charles J. Blijdorp, Niek F. Casteleijn, Hedwig M. A. D‘Agnolo, Shosha E.I. Dekker, Joost P.H. Drenth, Johan W. de Fijter, Maatje D.A. van Gastel, Tom J.G. Gevers, Marten A. Lantinga, Monique Losekoot, A. Lianne Messchendorp, Myrte K. Neijenhuis, Michelle J. Pena, Dorien J.M. Peters, Mahdi Salih, Darius Soonawala, Edwin M. Spithoven, Jack F.M. Wetzels, Robert Zietse, Ron T. Gansevoort
Baskı/Yayın Bilgisi 2018Artigo -
6
Clinical Outcomes of Covid-19 in Patients With Inflammatory Bowel Disease: A Nationwide Cohort Study Yazar: Lauranne Derikx, Marten A. Lantinga, Dirk J. de Jong, Willemijn A. van Dop, Rob H. Creemers, Tessa E H Römkens, Jeroen M. Jansen, Nofel Mahmmod, Rachel West, Adriaan C.I.T.L. Tan, Alexander Bodelier, Moniek H P Gorter, Paul J. Boekema, Eric R C Halet, Carmen S. Horjus, M.A. van Dijk, Meike M. Hirdes, Ludger S.M. Epping Stippel, Bindia Jharap, Maurice Lutgens, Maurice G. Rüssel, Lennard P. L. Gilissen, S. H. M. Nauta, Adriaan A. van Bodegraven, Frank Hoentjen
Baskı/Yayın Bilgisi 2020Artigo -
7
Lanreotide Reduces Liver Growth In Patients With Autosomal Dominant Polycystic Liver and Kidney Disease Yazar: R. Aerts, Wietske Kievit, Hedwig M. A. D‘Agnolo, Charles J. Blijdorp, Niek F. Casteleijn, Shosha E.I. Dekker, Johan W. de Fijter, Maatje D.A. van Gastel, Tom J.G. Gevers, Liyanne F. M. van de Laarschot, Marten A. Lantinga, Monique Losekoot, Esther Meijer, A. Lianne Messchendorp, Myrte K. Neijenhuis, Michelle J. Pena, Dorien J.M. Peters, Mahdi Salih, Darius Soonawala, Edwin M. Spithoven, Folkert W. Visser, Jack F.M. Wetzels, Robert Zietse, Ron T. Gansevoort, Joost P.H. Drenth
Baskı/Yayın Bilgisi 2019Artigo
Arama Araçları:
İlgili Konular
Internal medicine
Medicine
Autosomal dominant polycystic kidney disease
Disease
Gastroenterology
Intensive care medicine
Kidney
Kidney disease
Pathology
Polycystic kidney disease
Acromegaly
Coronavirus disease 2019 (COVID-19)
Cyst
Endoscopy
Growth hormone
Hormone
Infectious disease (medical specialty)
Lanreotide
Liver transplantation
Polycystic liver disease
Randomized controlled trial
Surgery
Transplantation
Urology
2019-20 coronavirus outbreak
Cancer
Clinical endpoint
Cohort
Cohort study
Colonoscopy